Company profile

BB Biotech AG insider transactions

BBBIOTECH

Management transactions

7

Shareholding disclosures

88

First disclosure

24.02.1999

Last disclosure

13.08.2026

Company summary

No management purchase or sale disclosed in the last 90 days.

Latest purchase
CHF 40’894

05.03.2025 · Non-executive member of the board of directors

Net flow 90 d
CHF 0.00

Buys − sales

Top shareholder
5.034%

UBS Fund Management Switzerland AG

Latest priced trade (05.03.2025): CHF 41 k, 0.7× the median of 5 earlier same-direction trades over one year. Compare with its own history, not another company’s.

This page brings together all BB Biotech AG (BBBIOTECH) insider transactions: 7 management transactions and 88 significant shareholding disclosures published by SIX Exchange Regulation, from 24.02.1999 to 13.08.2026.

Detailed context

A total of 7 management transactions and 88 significant shareholding disclosures have been published by SIX Exchange Regulation regarding BB Biotech AG, providing transparency into insider transactions. Over the last 90 days, there were 0 purchases and 0 sales recorded, resulting in a total volume of CHF 0 for both categories. The latest management transaction date occurred on 2025-03-05. The largest declared shareholders by voting rights include WestLB Mellon Asset Management Kapitalanlage-Gesellsch. mbH at 9.45%, followed by DWS Austria Investmentgesellschaft mbH, DWS Investment GmbH, and DWS Investment S.A, each holding 8.26%.

Insider barometer

90 days

No transaction in this window

Latest transaction

05.03.2025

Largest purchase

CHF 874’766

Largest sale

—

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Follow BB Biotech AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

BB Biotech AG insider transactions

Latest shareholding disclosures